Tango Therapeutics, INC. (TNGX) — SC 13D/A Filings
All SC 13D/A filings from Tango Therapeutics, INC.. Browse 4 SC 13D/A reports with AI-powered summaries and risk analysis.
SC 13D/A Filings (4)
-
Boxer Capital Ups Tango Therapeutics Stake to 14.9%
— Nov 7, 2024 Risk: medium
Boxer Capital Management, LLC, along with related entities and individuals, has filed an amendment (Amendment No. 6) to their Schedule 13D concerning Tango Ther -
Boxer Capital Ups Tango Therapeutics Stake
— Oct 28, 2024 Risk: medium
Boxer Capital Management, LLC, along with affiliated entities, has amended its Schedule 13D filing concerning Tango Therapeutics, Inc. as of October 28, 2024. T -
Boxer Asset Management Amends Tango Therapeutics Stake
— Oct 15, 2024 Risk: medium
Boxer Asset Management Inc. filed an amendment (No. 4) to its Schedule 13D on October 15, 2024, regarding its holdings in Tango Therapeutics, Inc. The filing in -
Third Rock Ventures Amends Tango Therapeutics Stake
— Sep 4, 2024 Risk: medium
Third Rock Ventures IV, L.P. filed an amendment (No. 1) to its Schedule 13D on August 30, 2024, regarding its holdings in Tango Therapeutics, Inc. The filing in
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX